Overcrowded and Under-monitored: Helping Improve Patient Safety in Emergency Departments
Speakers
It’s no secret that Emergency Departments are overcrowded and face operational and patient safety challenges amid workforce shortages and increasingly complex patients. Continuous vital sign monitoring drives earlier detection of deterioration, particularly for those patients waiting in triage or boarding for extended periods of time and whose decline may be missed by spot checks. When layered on top of spot checking, wireless, wearable monitoring for patients can provide a crucial safety check that lowers clinicians’ cognitive burden and help drive better outcomes for the rest of the patient’s journey inside and outside the hospital. This webinar will describe both the current pain points and the new opportunities for vital sign monitoring in Emergency Departments, and how newer technologies could advance patient care and hospital economics.
Dr. Kyle Gunnerson
Professor of Emergency Medicine, Anesthesiology, and Internal Medicine/Critical Care
Dr. Gunnerson has been clinically active in both the Cardiovascular ICU and Emergency Department for more than 20 years. Dr. Gunnerson’s research includes several large collaborative projects funded by both industry and governmental funding agencies. These have ranged from the discovery and development of novel biomarkers in critical illness to the treatment of severe sepsis and septic shock. He has also been active in the development of non-invasive technology used for the identification and treatment of patients with critical illness and injury and was a co-investigator of the first ED based ECMO clinical trial for refractory cardiac arrest. Dr. Gunnerson was the inaugural Chief of the Division of Critical Care in the UM Department of Emergency Medicine and a founder of the Emergency Critical Care Center, the first ICU within an Emergency Department in the US. With extensive experience managing complex cardiac surgery patients and extracorporeal support, he has been instrumental in advancing Emergency Critical Care as a specialty and serves on the board of the Society of Critical Care Medicine.
Dr. Robert N. Bilkovski, MD, MBA
President, RNB Ventures Consulting Inc.
Dr. Bilkovski has broad management experience, having served in leadership roles in multiple Fortune 500 companies overseeing medical affairs and clinical development in IVD, medical device, and pharmaceuticals industries. Some of the companies where he served in leadership roles include Hospira, GE HealthCare, Abbott Laboratories, and Becton Dickinson. Robert currently is the President of RNB Ventures Consulting Inc. providing strategic consulting in the field of medical and clinical affairs for medical device and diagnostic companies.
Dr. Bilkovski received his undergraduate degree in biochemistry with a focus in genetic engineering at McMaster University in Hamilton, Ontario, Canada. Robert completed his medical training at Rosalind Franklin University/The Chicago Medical School and subsequently pursued specialization in emergency medicine. Lastly, Dr. Bilkovski earned his MBA at the University of Notre Dame as part of his transition from clinical medicine to medical industry.
